Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 116Terminated 35Unknown 14Withdrawn 8Active not recruiting 5Recruiting 4Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 5

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Breast 2Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Rectal Neoplasms 1Prostatic Neoplasms 1Colorectal Neoplasms 1Carcinoma, Medullary 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 183Nivolumab 181Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 110Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74atezolizumab 72Radiation 72fludarabine 68Standard of Care 68Gemcitabine 68venetoclax 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Immunohistochemistry × Clear all
NCT07597369 2026-05-19

Clinically Actionable Tumor-Associated Antigens in Prostate Cancer

Peking University First Hospital

Active not recruiting
1,600 enrolled
Genitourinary

Prostatic Neoplasms

NCT00335816 2026-01-14

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
248 enrolled
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT01196936 2026-01-05

LDTam

University of Alabama at Birmingham

Phase 2 Active not recruiting
84 enrolled 17 charts
Breast

Breast Neoplasms

NCT01093612 2025-11-14

Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer

City of Hope Medical Center

Phase NA Active not recruiting
18 enrolled 6 charts
Breast

Breast Neoplasms

NCT04970134 2024-09-19

MOLTHY

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Active not recruiting
150 enrolled

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡